MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

Methimazole

  • Home
  • Methimazole
Synergistic Supplementation: How L-Carnitine and Selenium Enhance Methimazole Efficacy in Graves’ Disease
Posted inDiabetes & Endocrinology Internal Medicine news

Synergistic Supplementation: How L-Carnitine and Selenium Enhance Methimazole Efficacy in Graves’ Disease

Posted by By MedXY 01/01/2026
A randomized trial reveals that adding L-carnitine and selenium to methimazole therapy significantly accelerates TRAb negativity, increases remission rates, and reduces cumulative drug exposure in patients with Graves' disease.
Read More
Enhancing Graves’ Disease Treatment: The Benefits of Adding L-Carnitine and Selenium to Methimazole Therapy
Posted inDiabetes & Endocrinology news Specialties

Enhancing Graves’ Disease Treatment: The Benefits of Adding L-Carnitine and Selenium to Methimazole Therapy

Posted by By MedXY 09/20/2025
A recent randomized trial shows that supplementing methimazole with L-carnitine and selenium in Graves' disease shortens disease duration, lowers antibody levels faster, reduces medication dose, and improves select symptoms, highlighting a promising adjunctive therapy.
Read More
  • Frailty as a Predictor of Surgical Outcomes in Cricopharyngeus Muscle Dysfunction: Enhancing Patient Selection and Expectations
  • Histopathologic Insights in Chronic Rhinosinusitis Linked to Intranasal Substance Use: Implications for Clinical Management
  • Environmental Burden and Its Influence on Surgical Outcomes: Unveiling the Hidden Disparities
  • Advancing Surgical Quality Assessment in Distal Gastrectomy: Automated Evaluation of the Critical View of Quality Using Computer Vision
  • Neurotensin Receptor 1: A Key Driver of Immune Exclusion and Poor Prognosis in Colorectal Cancer
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification semaglutide SGLT2 inhibitors stroke type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top